Abstract
This chapter represents the core of this study and presents the main findings. The aim of this chapter is threefold. First, it offers in-depth explanations of the adverse drug reaction (ADR) reporting systems, and it describes relevant tasks and actors involved in all six countries under consideration (the United Kingdom, Finland, Poland, France, Portugal and Germany).
Chapter PDF
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
ANSM (2016). Annual Report 2015. Last accessed on 04.11.2016: ansm.sante.fr/content/download/97375/1237039/…/ANSM-RA-15_EN_oct2016.pdf
AkdÄ (2016). Tätigkeitsbericht 2015. Last accessed on 02.12.2016: www.akdae.de/Kommission/Organisation/Aufgaben/Taetigkeitsbericht.pdf
Bronder, E., Stammschulte, T. (2013). Nebenwirkungen von Arzneimitteln: Meldung an die Arzneimittelkommission der deutschen Ärzteschaft, Erfassung in einer Datenbank und Bewertung. Ärzteblatt Thüringen, Ausgabe 12/2013: 670-672.
Caron, J., Gautier, S., Mallaret, M. (2014). Spontaneous Reporting: France. Andrews, E., Moore, N. (eds) (2014). Mann’s Pharmacovigilance. Wiley-Blackwell.
Casassus, B. (2016). Drug Scandals in France: Have the Lessons Been Learnt? The Lancet 2016/388: 550-552.
Duarte, M., Ferreira, P., Soares, M., Cavaco, A., Martins, A. P. (2015). Community Pharmacists’ Attitudes towards Adverse Drug Reaction Reporting and their Knowledge of the New Pharmacovigilance Legislation in the Southern Region of Portugal: A Mixed Methods Study. Drugs and Therapy Perspectives 31 (9): 316-322.
EMA (2013). Medication Errors Workshop – Workshop Report. EMA/144458/2013 Patient Health Protection 06.05.2013.
Fimea (2010). Guideline 2/2010 – Reporting of Adverse Drug Reactions. Last accessed on 22.05.2016: https://www.fimea.fi/documents/542809/844142/17296_Ohje_2_2010_Haittavaikutusten_ilmoittaminen_EN.pdf.
Fimea Administrative Guidelines 2/2013 (2013). Reporting of Adverse Drug Reactions, 3428/03.01.01/2012. Last accessed on 22.05.2016: https://www.fimea.fi/…/23514_Ohje_2_2013_EN.pdf
Finnish Communicable Diseases Act (583/1986). Last accessed on 22.05.2016: www.finlex.fi/fi/laki/kaannokset/1986/en19860583.pdf
Foy, M. (2015). eHealth – The Road towards More Efficient and Integrated Care Solutions for Patients. Presentation for MHRA.
Hagemann, U., Paeschke, N. (2014). How Pharmacovigilance Is Organised in Germany. In: Andrews, E., Moore, N. (eds) (2014). Mann’s Pharmacovigilance. Wiley-Blackwell Oxford.
Inácio, P., Airaksinen, M., Cavaco, A. (2015). Language Does Not Come “in Boxes”: Assessing Discrepancies between Adverse Drug Reactions Spontaneous Reporting and MedDRA® Codes in European Portuguese. Research in Social and Administrative Pharmacy 11: 664-674.
INFARMED (2011). Boletim de Farmacovigilânica. Boletim de Farmacovigilância 15 (2).
INFARMED (2016). Boletim de Farmacovigilânica. Boletim de Farmacovigilância 20 (2).
Marques, J. I. O., Polonia, J. M. J., Figueiras, A. G., Santos, C. M., Herdeiro, M. F. (2016). Nurses’ Attitudes and Spontaneous Adverse Drug Reaction Reporting: A Case-Control Study in Portugal. Journal of Nursing Management 24: 409-416.
Matos, C., Van Hunsel, F., Joaquim, J. (2015). Are Consumers Ready to Take Part in the Pharmacovigilance System? A Portuguese Preliminary Study Concerning ADR Reporting. European Journal of Clinical Pharmacology 71: 883-890.
Mendes, D., Alves, C., Batel-Marques, F. (2014). Safety Profiles of Adalimumab, Etanercept and Infliximab: A Pharmacovigilance Study Using a Measure of Disproportionality in a Database of Spontaneously Reported Adverse Events. Journal of Clinical Pharmacy and Therapeutics 39: 307-313.
MHRA (2016). Guidance on Adverse Drug Reactions. Last accessed on 13.09.2016: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/403098/Guidance_on_adverse_drug_reactions.pdf
Mullard, A. (2011). Mediator Scandal Rocks French Medical Community. The Lancet 2011/377: 890-892.
Ribeiro-Vaz, I., Santos, C., Cruz-Correira, R. (2016). Promoting Adverse Drug Reaction Reporting: Comparison of Different Approaches. Revista Saúde Pública 50 (14): 1-9.
Santos, A. (n.d.). Direct Patient Reporting in the European Union: A Snapshot of Reporting Systems in Seven Member States. Health Action International. Last accessed on 02.12.2016: http://haiweb.org/publication/direct-patient-reporting-in-the-eu-a-snapshot-of-reporting-systems-in-seven-member-states/
THL (2016). National Institute for Health and Welfare – Vaccinations. Last accessed on 04.10.2016: https://www.thl.fi/fi/web/thlfi-en/statistics/information-on-statistics/quality-descriptions/vaccinations
URPL (2015). Jak zgłaszać działania niepożądane (How to Report Side Effects). On Youtube posted by URPLWMiPB on 10.02.2015. Last accessed on 25.09.2016: https://www.youtube.com/watch?v=mE_EbeE7ado&feature=youtu.be
URPL (2014). Zgłaszanie działań niepożądanych (Reporting Adverse Events). On Youtube posted by URPLWMiPB on 14.02.2014. Last accessed on 25.09.2016: https://www.youtube.com/watch?v=g2H8BOq0UOc
Yellow Card Centre Wales (n.d.). Annual Report Year 2013-2014. Last accessed 13.09.2016: http://www.yellowcardwales.org/pdfs/YCCW%20Annual%20Report%202013-14-%20Final.pdf
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This chapter is licensed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
The images or other third party material in this book are included in the book's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the book's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Copyright information
© 2017 The Author(s)
About this chapter
Cite this chapter
Kaeding, M., Schmälter, J., Klika, C. (2017). Practical Implementation in Six Member States. In: Pharmacovigilance in the European Union. Springer, Wiesbaden. https://doi.org/10.1007/978-3-658-17276-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-658-17276-3_5
Published:
Publisher Name: Springer, Wiesbaden
Print ISBN: 978-3-658-17275-6
Online ISBN: 978-3-658-17276-3
eBook Packages: Political Science and International StudiesPolitical Science and International Studies (R0)